Christopher Morrison, PhD

Christopher Morrison, PhD

Senior Vice President, CMC @ Avista Therapeutics

About

Energetic, driven professional with a focused background in recombinant adeno-associated viral vector (rAAV) CMC, inclusive of Technical Operations, Regulatory CMC, Quality Assurance and CMC Program Management. Experienced leader responsible for management of products from candidate selection to Phase I/II filing, into late stage development activities and driving towards licensure in both US and ex-US markets. Proficient at both building new teams from the ground up and expanding/reorganizing existing departments focused on company growth. Experienced with building and managing external CDMO/CTO networks and work flow relationships with internal partners. Passionate about creating a team culture centered around high standards, colleague development, and participation with the greater field. Looking for the next challenge where I can contribute my knowledge, skills and experience towards building and developing an organization.

Country

United States

City

Arlington

Industry

Biotechnology

Skill

Protein Purification, Antibodies, Chromatography, Biotechnology, Biochemistry, Bioprocessing, Robotic High Throughput Screening, Displacement Chromatography, Hydroxyapatite, Purification, Protein Expression, Biopharmaceuticals, Flow Cytometry, Protein Chemistry, Molecular Biology, Technology Transfer, Good Manufacturing Practice (GMP)

Experience

Avista Therapeutics

Senior Vice President, CMC

Avista Therapeutics

LinkedIn
2024 - Present · 2 yrs

Pittsburgh, Pennsylvania (Boston, MA based)

Myrtelle

Senior Vice President - Head of Technical Operations

Myrtelle

LinkedIn
2021 - 2024 · 3 yrs

Boston, Massachusetts, United States

Adverum Biotechnologies

Vice President - Technology Development

Adverum Biotechnologies

LinkedIn
2020 - 2021 · 1 yr

Redwood City, CA (Boston, MA based)

Gemini Therapeutics

Senior Director - CMC Operations

Gemini Therapeutics

2019 - 2020 · 1 yr

Cambridge, MA

Voyager Therapeutics, Inc.

Director - Biopharmaceutical Development

Voyager Therapeutics, Inc.

LinkedIn
2018 - 2019 · 1 yr

Cambridge, Massacheusetts

Voyager Therapeutics, Inc.

Associate Director - Head of Process Development

Voyager Therapeutics, Inc.

LinkedIn
2016 - 2018 · 2 yrs

Cambridge, MA

Dimension Therapeutics (now part of Ultragenyx)

Associate Director - Head of Downstream Process Development

Dimension Therapeutics (now part of Ultragenyx)

2014 - 2016 · 2 yrs

Cambridge, MA

Pfizer

Principal Scientist - BioTherapeutics R&D

Pfizer

LinkedIn
2013 - 2014 · 1 yr

Andover, MA

Pfizer

Senior Scientist - BioTherapeutics R&D

Pfizer

LinkedIn
2010 - 2013 · 3 yrs

Andover, MA

Education

University of Wisconsin-Madison

University of Wisconsin-Madison

LinkedIn

Chemical Engineering

Rensselaer Polytechnic Institute

Rensselaer Polytechnic Institute

LinkedIn

Chemical and Biological Engineering

Prof. Steven Cramer Lab - Chromatographic Bioseparations

Christopher Morrison, PhD's Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.